(Q44557167)

4 December 2017

title

Sustained hypogammaglobulinemia under rituximab maintenance therapy could increase the risk for serious infections: a report of two cases (English)

1 reference

4 December 2017

1 reference

Emilio Besada

1

1 reference

4 December 2017

Lucius Bader

series ordinal

2

1 reference

4 December 2017

Hans Nossent

series ordinal

3

1 reference

4 December 2017

language of work or name

1 reference

30 December 2011

1 reference

Rheumatology International

4 December 2017

published in

1 reference

4 December 2017

volume

33

1 reference

4 December 2017

issue

6

1 reference

4 December 2017

page(s)

1643-1644

1 reference

https://scigraph.springernature.com/pub.10.1007/s00296-011-2353-5

4 December 2017

exact match

0 references

cites work

The effect of rituximab on humoral and cell mediated immunity and infection in the treatment of autoimmune diseases

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2353-5

Diagnostic strategy for patients with hypogammaglobulinemia in rheumatology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2353-5

Persistent panhypogammaglobulinemia with selected loss of memory B cells and impaired isotype expression after rituximab therapy for post-transplant EBV-associated autoimmune hemolytic anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2353-5

Profound hypogammaglobulinemia 7 years after treatment for indolent lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2353-5

Serum immunoglobulins and risk of infection: how low can you go?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2353-5

Risk factors for severe infections in patients with rheumatoid arthritis treated with rituximab in the autoimmunity and rituximab registry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2353-5

Does rituximab aggravate pre-existing hypogammaglobulinaemia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2353-5

Long-term follow-up of different refractory systemic vasculitides treated with rituximab

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22207199

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00296-011-2353-5

1 reference

4 December 2017

1 reference